{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:17:03Z","timestamp":1772165823515,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371508"],"award-info":[{"award-number":["82371508"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20200210"],"award-info":[{"award-number":["BK20200210"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2020661"],"award-info":[{"award-number":["BE2020661"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Administration of Traditional Chinese Medicine","award":["MS2022083"],"award-info":[{"award-number":["MS2022083"]}]},{"name":"Suzhou Municipal Sci-Tech Bureau Program","award":["SKY2023225"],"award-info":[{"award-number":["SKY2023225"]}]},{"name":"the Sample Bank of Suzhou Municipal Psychiatric Disorders supported by Suzhou Municipal Finance Bureau."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07612-7","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T14:46:53Z","timestamp":1763218013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decreased serum VEGF levels and their negative correlation with cognitive function in patients with major depressive disorder: a case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhenhua","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"7612_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev-clinpsy-072220-021440","volume":"18","author":"SM Monroe","year":"2022","unstructured":"Monroe SM, Harkness KL. Major depression and its recurrences: life course matters. Ann Rev Clin Psychol. 2022;18:329\u201357.","journal-title":"Ann Rev Clin Psychol"},{"issue":"2","key":"7612_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/acps.13385","volume":"145","author":"S Varghese","year":"2022","unstructured":"Varghese S, Frey BN, Schneider MA, Kapczinski F, de Azevedo Cardoso T. Functional and cognitive impairment in the first episode of depression: A systematic review. Acta Psychiatrica Scandinavica. 2022;145(2):156\u201385.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"7612_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/YCO.0000000000000378","volume":"31","author":"MJ Knight","year":"2018","unstructured":"Knight MJ, Baune BT. Cognitive dysfunction in major depressive disorder. Curr Opin Psychiatry. 2018;31(1):26\u201331.","journal-title":"Curr Opin Psychiatry"},{"issue":"17","key":"7612_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s40265-016-0655-3","volume":"76","author":"JE Frampton","year":"2016","unstructured":"Frampton JE. Vortioxetine: A review in cognitive dysfunction in depression. Drugs. 2016;76(17):1675\u201382.","journal-title":"Drugs"},{"issue":"1","key":"7612_CR5","first-page":"18","volume":"71","author":"GM MacQueen","year":"2017","unstructured":"MacQueen GM, Memedovich KA. Cognitive dysfunction in major depression and bipolar disorder: assessment and treatment options. J Neuropsychiatry Clin Neurosci. 2017;71(1):18\u201327.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"7612_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","volume":"197","author":"AN Sharma","year":"2016","unstructured":"Sharma AN, da Costa e Silva BF, Soares JC, Carvalho AF, Quevedo J. Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies. J Affect Disord. 2016;197:9\u201320.","journal-title":"J Affect Disord"},{"issue":"4","key":"7612_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2174\/157015911798376262","volume":"9","author":"FL Neto","year":"2011","unstructured":"Neto FL, Borges G, Torres-Sanchez S, Mico JA, Berrocoso E. Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol. 2011;9(4):530\u201352.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"7612_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coph.2006.08.009","volume":"7","author":"E Castr\u00e9n","year":"2007","unstructured":"Castr\u00e9n E, V\u00f5ikar V, Rantam\u00e4ki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2007;7(1):18\u201321.","journal-title":"Curr Opin Pharmacol"},{"issue":"1601","key":"7612_CR9","first-page":"2475","volume":"367","author":"RS Duman","year":"2012","unstructured":"Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philosophical Trans Royal Soc Lond Ser B Biol Sci. 2012;367(1601):2475\u201384.","journal-title":"Philosophical Trans Royal Soc Lond Ser B Biol Sci"},{"key":"7612_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.pnpbp.2012.09.009","volume":"40","author":"PT Tseng","year":"2013","unstructured":"Tseng PT, Lee Y, Lin PY. Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder. Prog Neuro-psychopharmacol Biol Psychiatry. 2013;40:334\u20139.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"12","key":"7612_CR11","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","volume":"59","author":"RS Duman","year":"2006","unstructured":"Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59(12):1116\u201327.","journal-title":"Biol Psychiatry"},{"issue":"26","key":"7612_CR12","doi-asserted-by":"publisher","first-page":"e2202912119","DOI":"10.1073\/pnas.2202912119","volume":"119","author":"PM Calvo","year":"2022","unstructured":"Calvo PM, Hern\u00e1ndez RG, de la Cruz RR, Pastor AM. VEGF is an essential retrograde trophic factor for motoneurons. Proc Natl Acad Sci USA. 2022;119(26):e2202912119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"7612_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1152\/physrev.00031.2008","volume":"89","author":"C Ruiz de Almodovar","year":"2009","unstructured":"Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev. 2009;89(2):607\u201348.","journal-title":"Physiol Rev"},{"issue":"10","key":"7612_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1177\/154405910708601006","volume":"86","author":"J Dai","year":"2007","unstructured":"Dai J, Rabie AB. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res. 2007;86(10):937\u201350.","journal-title":"J Dent Res"},{"issue":"6","key":"7612_CR15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/jcb.21579","volume":"102","author":"EC Breen","year":"2007","unstructured":"Breen EC. VEGF in biological control. J Cell Biochem. 2007;102(6):1358\u201367.","journal-title":"J Cell Biochem"},{"issue":"4","key":"7612_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581\u2013611.","journal-title":"Endocr Rev"},{"issue":"3","key":"7612_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.pnpbp.2006.12.011","volume":"31","author":"J Iga","year":"2007","unstructured":"Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, Nakataki M, Song H, Hokoishi K, Tanabe H, et al. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog Neuro-psychopharmacol Biol Psychiatry. 2007;31(3):658\u201363.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"7","key":"7612_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00406-018-0953-8","volume":"269","author":"L Nguyen","year":"2019","unstructured":"Nguyen L, Kakeda S, Katsuki A, Sugimoto K, Otsuka Y, Ueda I, Igata R, Watanabe K, Kishi T, Iwata N, et al. Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-na\u00efve patients with first-episode major depressive disorder. Eur Arch Psychiatry Clin NeuroSci. 2019;269(7):785\u201394.","journal-title":"Eur Arch Psychiatry Clin NeuroSci"},{"issue":"6","key":"7612_CR19","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.18632\/aging.203984","volume":"14","author":"AM Petrelis","year":"2022","unstructured":"Petrelis AM, Stathopoulou MG, Kafyra M, Murray H, Masson C, Lamont J, Fitzgerald P, Dedoussis G, Yen FT, Visvikis-Siest S. VEGF-A-related genetic variants protect against alzheimer\u2019s disease. Aging. 2022;14(6):2524\u201336.","journal-title":"Aging"},{"issue":"1","key":"7612_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nn1360","volume":"8","author":"E Storkebaum","year":"2005","unstructured":"Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci. 2005;8(1):85\u201392.","journal-title":"Nat Neurosci"},{"issue":"1","key":"7612_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12943-019-0950-1","volume":"18","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Shi S, Yuan Z, Chang JY. Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues. Mol Cancer. 2019;18(1):21.","journal-title":"Mol Cancer"},{"issue":"10","key":"7612_CR22","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1007\/s10803-020-04820-w","volume":"51","author":"F \u015eim\u015fek","year":"2021","unstructured":"\u015eim\u015fek F, I\u015f\u0131k \u00dc, Aktepe E, K\u0131l\u0131\u00e7 F, \u015eirin FB, Bozkurt M. Comparison of serum VEGF, IGF-1, and HIF-1\u03b1 levels in children with autism spectrum disorder and healthy controls. J Autism Dev Disord. 2021;51(10):3564\u201374.","journal-title":"J Autism Dev Disord"},{"key":"7612_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jpsychires.2014.08.005","volume":"59","author":"A Clark-Raymond","year":"2014","unstructured":"Clark-Raymond A, Meresh E, Hoppensteadt D, Fareed J, Sinacore J, Halaris A. Vascular endothelial growth factor: a potential diagnostic biomarker for major depression. J Psychiatr Res. 2014;59:22\u20137.","journal-title":"J Psychiatr Res"},{"issue":"8","key":"7612_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3109\/15622975.2015.1117655","volume":"18","author":"A Clark-Raymond","year":"2017","unstructured":"Clark-Raymond A, Meresh E, Hoppensteadt D, Fareed J, Sinacore J, Garlenski B, Halaris A. Vascular endothelial growth factor: potential predictor of treatment response in major depression. World J Biol Psychiatry. 2017;18(8):575\u201385.","journal-title":"World J Biol Psychiatry"},{"key":"7612_CR25","doi-asserted-by":"publisher","first-page":"113319","DOI":"10.1016\/j.psychres.2020.113319","volume":"292","author":"J Pu","year":"2020","unstructured":"Pu J, Liu Y, Gui S, Tian L, Xu S, Song X, Zhong X, Chen Y, Chen X, Yu Y, et al. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis. Psychiatry Res. 2020;292:113319.","journal-title":"Psychiatry Res"},{"issue":"2","key":"7612_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270\u20136.","journal-title":"Nat Med"},{"issue":"6","key":"7612_CR27","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","volume":"11","author":"HM Snyder","year":"2015","unstructured":"Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, et al. Vascular contributions to cognitive impairment and dementia including alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2015;11(6):710\u20137.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"issue":"1","key":"7612_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola C. The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease. Neuron. 2017;96(1):17\u201342.","journal-title":"Neuron"},{"issue":"1","key":"7612_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12888-023-04616-z","volume":"23","author":"Y Cai","year":"2023","unstructured":"Cai Y, Zhu ZH, Li RH, Yin XY, Chen RF, Man LJ, Hou WL, Zhu HL, Wang J, Zhang H, et al. Association between increased serum interleukin-8 levels and improved cognition in major depressive patients with SSRIs. BMC Psychiatry. 2023;23(1):122.","journal-title":"BMC Psychiatry"},{"key":"7612_CR30","doi-asserted-by":"publisher","first-page":"858675","DOI":"10.3389\/fpsyt.2022.858675","volume":"13","author":"ZH Zhu","year":"2022","unstructured":"Zhu ZH, Song XY, Man LJ, Chen P, Tang Z, Li RH, Ji CF, Dai NB, Liu F, Wang J, et al. Comparisons of serum Interleukin-8 levels in major depressive patients with Drug-Free versus SSRIs versus healthy controls. Front Psychiatry. 2022;13:858675.","journal-title":"Front Psychiatry"},{"issue":"3","key":"7612_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","volume":"20","author":"C Randolph","year":"1998","unstructured":"Randolph C, Tierney MC, Mohr E, Chase TN. The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20(3):310\u20139.","journal-title":"J Clin Exp Neuropsychol"},{"key":"7612_CR32","unstructured":"Zhang BH, Tan YL, Zhang WF, Wang ZR, Zhou DFJCMHJ. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) as a screening test in Chinese: reliability and validity. 2008."},{"issue":"1","key":"7612_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1017\/S1092852918001207","volume":"24","author":"Z Pan","year":"2019","unstructured":"Pan Z, Park C, Brietzke E, Zuckerman H, Rong C, Mansur RB, Fus D, Subramaniapillai M, Lee Y, McIntyre RS. Cognitive impairment in major depressive disorder. CNS Spectr. 2019;24(1):22\u20139.","journal-title":"CNS Spectr"},{"issue":"2\u20133","key":"7612_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12017-017-8458-6","volume":"19","author":"L Wang","year":"2017","unstructured":"Wang L, Wang J, Wang F, Liu C, Yang X, Yang J, Ming D. VEGF-Mediated cognitive and synaptic improvement in chronic cerebral hypoperfusion rats involves autophagy process. Neuromol Med. 2017;19(2\u20133):423\u201335.","journal-title":"Neuromol Med"},{"issue":"1","key":"7612_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmed.2003.11.006","volume":"10","author":"DA Greenberg","year":"2004","unstructured":"Greenberg DA, Jin K. VEGF and ALS: the luckiest growth factor? Trends Mol Med. 2004;10(1):1\u20133.","journal-title":"Trends Mol Med"},{"issue":"8","key":"7612_CR36","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jpsychires.2013.04.008","volume":"47","author":"A Clark-Raymond","year":"2013","unstructured":"Clark-Raymond A, Halaris A. VEGF and depression: a comprehensive assessment of clinical data. J Psychiatr Res. 2013;47(8):1080\u20137.","journal-title":"J Psychiatr Res"},{"key":"7612_CR37","doi-asserted-by":"crossref","unstructured":"Becerril-Villanueva E, P\u00e9rez-S\u00e1nchez G, Alvarez-Herrera S, Gir\u00f3n-P\u00e9rez MI, Arreola R, Cruz-Fuentes C, Palacios L, de la Pe\u00f1a FR, Pav\u00f3n L. alterations in the levels of growth factors in adolescents with major depressive disorder: a longitudinal study during the treatment with fluoxetine. Mediators of Inflamm 2019, 2019:9130868.","DOI":"10.1155\/2019\/9130868"},{"issue":"1","key":"7612_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pnpbp.2008.11.009","volume":"33","author":"M Ventriglia","year":"2009","unstructured":"Ventriglia M, Zanardini R, Pedrini L, Placentino A, Nielsen MG, Gennarelli M, Bocchio-Chiavetto L. VEGF serum levels in depressed patients during SSRI antidepressant treatment. Prog Neuro-psychopharmacol Biol Psychiatry. 2009;33(1):146\u20139.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"7612_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.psyneuen.2015.07.002","volume":"62","author":"AF Carvalho","year":"2015","unstructured":"Carvalho AF, K\u00f6hler CA, McIntyre RS, Kn\u00f6chel C, Brunoni AR, Thase ME, Quevedo J, Fernandes BS, Berk M. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis. Psychoneuroendocrinology. 2015;62:18\u201326.","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"7612_CR40","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.pnpbp.2011.04.013","volume":"35","author":"A Minelli","year":"2011","unstructured":"Minelli A, Zanardini R, Abate M, Bortolomasi M, Gennarelli M, Bocchio-Chiavetto L. Vascular endothelial growth factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. Prog Neuro-psychopharmacol Biol Psychiatry. 2011;35(5):1322\u20135.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"7612_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0079-6123(08)01138-2","volume":"173","author":"S Pucci","year":"2008","unstructured":"Pucci S, Mazzarelli P, Missiroli F, Regine F, Ricci F. Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the Moon. Prog Brain Res. 2008;173:555\u201373.","journal-title":"Prog Brain Res"},{"issue":"9","key":"7612_CR42","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/bies.20092","volume":"26","author":"E Storkebaum","year":"2004","unstructured":"Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays: News Reviews Mol Cell Dev Biology. 2004;26(9):943\u201354.","journal-title":"BioEssays: News Reviews Mol Cell Dev Biology"},{"issue":"2","key":"7612_CR43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12017-013-8284-4","volume":"16","author":"J Yang","year":"2014","unstructured":"Yang J, Yao Y, Chen T, Zhang T. VEGF ameliorates cognitive impairment in in vivo and in vitro ischemia via improving neuronal viability and function. Neuromol Med. 2014;16(2):376\u201388.","journal-title":"Neuromol Med"},{"issue":"2","key":"7612_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.expneurol.2008.08.014","volume":"214","author":"K Plaschke","year":"2008","unstructured":"Plaschke K, Staub J, Ernst E, Marti HH. VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol. 2008;214(2):285\u201392.","journal-title":"Exp Neurol"},{"issue":"5","key":"7612_CR45","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.neurobiolaging.2012.10.029","volume":"34","author":"H Tang","year":"2013","unstructured":"Tang H, Mao X, Xie L, Greenberg DA, Jin K. Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with alzheimer\u2019s disease. Neurobiol Aging. 2013;34(5):1412\u20135.","journal-title":"Neurobiol Aging"},{"key":"7612_CR46","doi-asserted-by":"publisher","first-page":"263310552211092","DOI":"10.1177\/26331055221109254","volume":"17","author":"M Ali","year":"2022","unstructured":"Ali M, Bracko O. VEGF paradoxically reduces cerebral blood flow in alzheimer\u2019s disease mice. Neurosci Insights. 2022;17:26331055221109254.","journal-title":"Neurosci Insights"},{"issue":"3","key":"7612_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40263-023-00989-7","volume":"37","author":"SJ Tsai","year":"2023","unstructured":"Tsai SJ, Kao CF, Su TP, Li CT, Lin WC, Hong CJ, Bai YM, Tu PC, Chen MH. Cytokine- and vascular endothelial growth Factor-Related Gene-Based Genome-Wide association study of Low-Dose ketamine infusion in patients with Treatment-Resistant depression. CNS Drugs. 2023;37(3):243\u201353.","journal-title":"CNS Drugs"},{"issue":"12","key":"7612_CR48","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","volume":"20","author":"C Menard","year":"2017","unstructured":"Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20(12):1752\u201360.","journal-title":"Nat Neurosci"},{"issue":"6","key":"7612_CR49","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1073\/pnas.1914655117","volume":"117","author":"KA Dudek","year":"2020","unstructured":"Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, Ferrer Perez C, Golden SA, Tamminga C, Turecki G, et al. Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression. Proc Natl Acad Sci USA. 2020;117(6):3326\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7612_CR50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbi.2018.02.003","volume":"69","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Desse S, Martinez A, Worthen RJ, Jope RS, Beurel E. TNF\u03b1 disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun. 2018;69:556\u201367.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"7612_CR51","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1038\/s41380-022-01618-3","volume":"27","author":"H Matsuno","year":"2022","unstructured":"Matsuno H, Tsuchimine S, O\u2019Hashi K, Sakai K, Hattori K, Hidese S, Nakajima S, Chiba S, Yoshimura A, Fukuzato N, et al. Association between vascular endothelial growth factor-mediated blood-brain barrier dysfunction and stress-induced depression. Mol Psychiatry. 2022;27(9):3822\u201332.","journal-title":"Mol Psychiatry"},{"issue":"15","key":"7612_CR52","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1017\/S0033291718000090","volume":"48","author":"G Ye","year":"2018","unstructured":"Ye G, Yin GZ, Tang Z, Fu JL, Chen J, Chen SS, Li J, Fu T, Yu X, Xu DW, et al. Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder. Psychol Med. 2018;48(15):2508\u201314.","journal-title":"Psychol Med"},{"issue":"5","key":"7612_CR53","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct\u00f4t KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446\u201357.","journal-title":"Biol Psychiatry"},{"issue":"12","key":"7612_CR54","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696\u2013709.","journal-title":"Mol Psychiatry"},{"key":"7612_CR55","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jpsychires.2024.06.037","volume":"176","author":"M Maes","year":"2024","unstructured":"Maes M, Zhou B, Vasupanrajit A, Jirakran K, Klomkliew P, Chanchaem P, Tunvirachaisakul C, Plaimas K, Suratanee A, Li J, et al. A further examination of growth factors, T helper 1 polarization, and the gut Microbiome in major depression: associations with reoccurrence of illness, cognitive functions, suicidal behaviors, and quality of life. J Psychiatr Res. 2024;176:430\u201341.","journal-title":"J Psychiatr Res"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07612-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:03:46Z","timestamp":1766505826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-025-07612-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7612"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07612-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5766380\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Suzhou Guangji Hospital (Ethical approval number: 2019-026). The study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1160"}}